CAS 221227-05-0: L-Arginine, N-(1-oxohexadecyl)glycyl-L-glutaminyl-L-prolyl-

Palmitoyl Tetrapeptide-3, a synthetic peptide, boosts GCP-2 to recruit cells for repair and cleanup.

Palmitoyl tetrapeptide 7 is a bacterial strain that has been shown to inhibit the proliferation of bacteria cells in vitro. It also inhibits the production of inflammatory cytokines and reactive oxygen species (ROS) by human skin cells. This product has been shown to be synergistic with other ingredients such as butanediol, glycerin, hydrogenated lecithin, and fatty acids. Palmitoyl tetrapeptide 7 is a bacterial strain that has been shown to inhibit the proliferation of bacteria cells in vitro. It also inhibits the production of inflammatory cytokines and reactive oxygen species (ROS) by human skin cells. This product has been shown to be synergistic with other ingredients such as butanediol, glycerin, hydrogenated lecithin, and fatty acids.

Palmitoyl tetrapeptide 7 trifluoroacetate is an anticancer agent that acts as a protein kinase inhibitor. It has been shown to inhibit the growth of cancer cells and induce apoptosis in human tumors. This peptide analog has been studied extensively for its potential use in cancer therapy due to its ability to suppress the activity of kinases, which are enzymes involved in cell signaling pathways that regulate cell growth and division. Palmitoyl tetrapeptide 7 trifluoroacetate has also been found to be effective against certain strains of influenza virus, such as H1N1, by inhibiting neuraminidase activity. This compound has been isolated from Chinese urine samples and is structurally similar to oseltamivir, a drug used to treat influenza infections.

Pal-GQPR or Palmitoyl Tetrapeptide-7/3 is a synthetic peptide that is used in cosmetics to suppress the production of excess interleukins, the chemical messengers which trigger the body’s acute inflammatory response. Therefore Pal-GQPR can inhibit unnecessary inappropriate inflammatory responses and glycation damage.

Palmitoyl Tetrapeptide-3